Literature DB >> 32499379

Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent.

Marianna M S Beyer1,2, Niklas Lonnemann1,2, Anita Remus1,2, Eicke Latz3,4, Michael T Heneka5,6, Martin Korte7,2.   

Abstract

Neuroinflammation can be caused by various insults to the brain and represents an important pathologic hallmark of neurodegenerative diseases including Alzheimer's disease (AD). Infection-triggered acute systemic inflammation is able to induce neuroinflammation and may negatively affect neuronal morphology, synaptic plasticity, and cognitive function. In contrast to acute effects, persisting consequences for the brain on systemic immune stimulation remain largely unexplored. Here, we report an age-dependent vulnerability of wild-type (WT) mice of either sex toward a systemic immune stimulation by Salmonella typhimurium lipopolysaccharide (LPS). Decreased neuronal complexity three months after peripheral immune stimulation is accompanied by impairment in long-term potentiation (LTP) and spatial learning. Aged APP/PS1 mice reveal an increased sensitivity also to LPS of Escherichia coli, which had no effect in WT mice. We further report that these effects are mediated by NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome activation, since the genetic ablation and pharmacological inhibition using the NLRP3 inhibitor MCC950 rescue the morphological and electrophysiological phenotype.SIGNIFICANCE STATEMENT Acute peripheral immune stimulation has been shown to have both positive and negative effects on Aβ deposition. Improvements or worsening may be possible in acute inflammation. However, there is still no evidence of effects longer than a month after stimulation. The data are pointing to an important role of the NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome for mediating the long-term consequences of systemic immune stimulation, which in addition turns out to be age dependent.
Copyright © 2020 the authors.

Entities:  

Keywords:  APP/PS1; LPS; NLRP3; hippocampus; neuroinflammation; sepsis

Mesh:

Substances:

Year:  2020        PMID: 32499379      PMCID: PMC7343321          DOI: 10.1523/JNEUROSCI.0200-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  57 in total

1.  Long-term cognitive impairment and functional disability among survivors of severe sepsis.

Authors:  Theodore J Iwashyna; E Wesley Ely; Dylan M Smith; Kenneth M Langa
Journal:  JAMA       Date:  2010-10-27       Impact factor: 56.272

2.  Deterioration of spatial learning performances in lipopolysaccharide-treated mice.

Authors:  K Arai; N Matsuki; Y Ikegaya; N Nishiyama
Journal:  Jpn J Pharmacol       Date:  2001-11

Review 3.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

4.  Effects of central and peripheral inflammation on hippocampal synaptic plasticity.

Authors:  Massimiliano Di Filippo; Davide Chiasserini; Fabrizio Gardoni; Barbara Viviani; Alessandro Tozzi; Carmela Giampà; Cinzia Costa; Michela Tantucci; Elisa Zianni; Mariaserena Boraso; Sabrina Siliquini; Antonio de Iure; Veronica Ghiglieri; Elisa Colcelli; David Baker; Paola Sarchielli; Francesca Romana Fusco; Monica Di Luca; Paolo Calabresi
Journal:  Neurobiol Dis       Date:  2013-01-04       Impact factor: 5.996

5.  Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model.

Authors:  Alexander Semmler; Christian Frisch; Thomas Debeir; Mutiah Ramanathan; Thorsten Okulla; Thomas Klockgether; Michael T Heneka
Journal:  Exp Neurol       Date:  2007-01-13       Impact factor: 5.330

6.  Innate immune receptor expression in normal brain aging.

Authors:  M Letiembre; W Hao; Y Liu; S Walter; I Mihaljevic; S Rivest; T Hartmann; K Fassbender
Journal:  Neuroscience       Date:  2007-02-09       Impact factor: 3.590

Review 7.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

8.  Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology.

Authors:  Jean-Philippe Michaud; Maxime Hallé; Antoine Lampron; Peter Thériault; Paul Préfontaine; Mohammed Filali; Pascale Tribout-Jover; Anne-Marie Lanteigne; Rachel Jodoin; Christopher Cluff; Vincent Brichard; Rémi Palmantier; Anthony Pilorget; Daniel Larocque; Serge Rivest
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-15       Impact factor: 11.205

9.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever.

Authors:  J G Cannon; R G Tompkins; J A Gelfand; H R Michie; G G Stanford; J W van der Meer; S Endres; G Lonnemann; J Corsetti; B Chernow
Journal:  J Infect Dis       Date:  1990-01       Impact factor: 5.226

10.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

View more
  12 in total

1.  IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer's disease mouse model.

Authors:  Niklas Lonnemann; Shirin Hosseini; Melanie Ohm; Robert Geffers; Karsten Hiller; Charles A Dinarello; Martin Korte
Journal:  Elife       Date:  2022-08-30       Impact factor: 8.713

Review 2.  A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?

Authors:  Stefania Merighi; Manuela Nigro; Alessia Travagli; Silvia Pasquini; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi; Stefania Gessi
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

Review 3.  Neurodegenerative Disease and the NLRP3 Inflammasome.

Authors:  Jonathan A Holbrook; Heledd H Jarosz-Griffiths; Emily Caseley; Samuel Lara-Reyna; James A Poulter; Caroline H Williams-Gray; Daniel Peckham; Michael F McDermott
Journal:  Front Pharmacol       Date:  2021-03-10       Impact factor: 5.810

4.  Repetitive Mild Closed Head Injury in Adolescent Mice Is Associated with Impaired Proteostasis, Neuroinflammation, and Tauopathy.

Authors:  Limin Wu; Brian T Kalish; Benjamin Finander; Tian Cao; Gina Jin; Taha Yahya; Emily S Levy; Bharti Kukreja; Eliza Sophie LaRovere; Joon Yong Chung; Eng H Lo; Alexander Brown-Whalen; Joseph El Khoury; David L Kaplan; Michael J Whalen
Journal:  J Neurosci       Date:  2022-02-01       Impact factor: 6.709

5.  Elamipretide (SS-31) Improves Functional Connectivity in Hippocampus and Other Related Regions Following Prolonged Neuroinflammation Induced by Lipopolysaccharide in Aged Rats.

Authors:  Yang Liu; Huiqun Fu; Yan Wu; Binbin Nie; Fangyan Liu; Tianlong Wang; Wei Xiao; Shuyi Yang; Minhui Kan; Long Fan
Journal:  Front Aging Neurosci       Date:  2021-03-01       Impact factor: 5.750

Review 6.  Thioredoxin-Interacting Protein (TXNIP) with Focus on Brain and Neurodegenerative Diseases.

Authors:  Haruka Tsubaki; Ikuo Tooyama; Douglas Gordon Walker
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923

Review 7.  NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically.

Authors:  Ainara González-Moro; Inés Valencia; Licia Shamoon; Carlos Félix Sánchez-Ferrer; Concepción Peiró; Fernando de la Cuesta
Journal:  Antioxidants (Basel)       Date:  2022-01-29

Review 8.  Cerebral dysfunctions caused by sepsis during ageing.

Authors:  Tatsuya Manabe; Michael T Heneka
Journal:  Nat Rev Immunol       Date:  2021-11-11       Impact factor: 108.555

Review 9.  The Impact of Systemic Inflammation on Alzheimer's Disease Pathology.

Authors:  Junhua Xie; Lien Van Hoecke; Roosmarijn E Vandenbroucke
Journal:  Front Immunol       Date:  2022-01-06       Impact factor: 7.561

Review 10.  Inflammasomes as therapeutic targets in human diseases.

Authors:  Yangxin Li; Hui Huang; Bin Liu; Yu Zhang; Xiangbin Pan; Xi-Yong Yu; Zhenya Shen; Yao-Hua Song
Journal:  Signal Transduct Target Ther       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.